Etanercept or infliximab are known to be effective in the treatment of psoriasis, in which T cells and dendritic cells activated by tumor necrosis factor (TNF) accumulate and produce cytokines such as TNF-α and IL-23 [124]. Here, TNF is linked to psoriasis.